Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Apr 10;12(1):e002672.
doi: 10.1136/bmjresp-2024-002672.

Tacrolimus versus cyclosporine immunosuppression in lung transplantation: a systematic review and meta-analysis

Tyler Pitre  1 , Samuel Gurupatham  2 , Kairavi Desai  3 , Matthew Binnie  2   4 , Tereza Martinu  2   4 , Stephen Juvet  2   4 , Dena Zeraatkar  5
Affiliations
Meta-Analysis

Tacrolimus versus cyclosporine immunosuppression in lung transplantation: a systematic review and meta-analysis

Tyler Pitre et al. BMJ Open Respir Res. .

Abstract

Background: The relative efficacy of calcineurin inhibitors tacrolimus and cyclosporine in lung transplantation remains unclear. To clarify, we conducted a systematic review and meta-analysis.

Methods: We searched through EMBASE, MEDLINE and Cochrane CENTRAL until 23 October 2023 for randomised trials comparing tacrolimus with cyclosporine in lung transplant recipients. Data extraction and bias risk assessment were done independently. Analyses included random effects pairwise meta-analysis and trial sequential analysis, with GRADE system for evidence certainty.

Results: We found four eligible trials totalling 662 patients. Tacrolimus significantly reduces the risk of chronic lung allograft dysfunction (RR 0.46, high certainty) and likely decreases acute rejection risk (RR 0.83, moderate certainty), with no clear difference in mortality (RR 1.08, low certainty). It may raise new-onset diabetes mellitus (RR 4.17, low certainty) and renal dysfunction risks (RR 1.27, low certainty).

Conclusion: Tacrolimus likely lowers acute rejection and chronic dysfunction risks in lung transplant recipients without improving survival rates. However, it might increase the chances of developing diabetes mellitus and renal dysfunction. These findings guide the choice between tacrolimus and cyclosporine, balancing benefits against potential risks.

Keywords: Lung Transplantation.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram of included and excluded studies.
Figure 2
Figure 2. Forest plot for chronic lung allograft dysfunction, presented as relative risk with 95% 95% CI.
Figure 3
Figure 3. Forest plot for acute rejection, presented as relative risk with 95% CI.
See this image and copyright information in PMC

References

    1. Cooper JD, Patterson GA, Grossman R, et al. Double-lung transplant for advanced chronic obstructive lung disease. Am Rev Respir Dis. 1989;139:303–7. doi: 10.1164/ajrccm/139.2.303. - DOI - PubMed
    1. Toronto Lung Transplant Group* Unilateral Lung Transplantation for Pulmonary Fibrosis. N Engl J Med. 1986;314:1140–5. doi: 10.1056/NEJM198605013141802. - DOI - PubMed
    1. Chambers DC, Cherikh WS, Harhay MO, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019;38:1042–55. doi: 10.1016/j.healun.2019.08.001. - DOI - PMC - PubMed
    1. Chambers DC, Perch M, Zuckermann A, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report - 2021; Focus on recipient characteristics. J Heart Lung Transplant. 2021;40:1060–72. doi: 10.1016/j.healun.2021.07.021. - DOI - PMC - PubMed
    1. Penninga L, Penninga EI, Møller CH, et al. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Cochrane Database Syst Rev. 2013:CD008817. doi: 10.1002/14651858.CD008817.pub2. - DOI - PubMed

MeSH terms

LinkOut - more resources